{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Administration safety", "Diabetic foot ulcer", "Mechanism of action", "Ozone therapy"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32534720", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "05"}, "DateRevised": {"Year": "2020", "Month": "10", "Day": "05"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "05", "Day": "13"}], "ELocationID": ["10.1016/j.amjms.2020.05.012", "S0002-9629(20)30185-3"], "Journal": {"ISSN": "1538-2990", "JournalIssue": {"Volume": "360", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Aug"}}, "Title": "The American journal of the medical sciences", "ISOAbbreviation": "Am J Med Sci"}, "ArticleTitle": "An Overview of Ozone Therapy for Treating Foot Ulcers in Patients With Diabetes.", "Pagination": {"StartPage": "112", "EndPage": "119", "MedlinePgn": "112-119"}, "Abstract": {"AbstractText": ["Diabetic foot ulcer (DFU) is one of the most common and severe complications of diabetes mellitus, which is becoming increasingly prevalent throughout the world, with high mortality and morbidity. Because of the complex pathophysiological processes involved, DFU is difficult to treat effectively with traditional therapies. Ozone therapy, an emerging method, has been reported as potentially beneficial for closure of DFUs and may gradually move to the forefront of clinical practice. Possible mechanisms of action include antioxidant capacity, pathogen inactivation, vascular and endogenous growth factor modulation, and immune system activation. However, some researchers are skeptical about its safety, and clinical trials are lacking. This article reviews the current research and application of ozone therapy for DFUs."], "CopyrightInformation": "Copyright \u00a9 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}], "LastName": "Wen", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China. Electronic address: chenqiu1005@cdutcm.edu.cn."}], "LastName": "Chen", "ForeName": "Qiu", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Med Sci", "NlmUniqueID": "0370506", "ISSNLinking": "0002-9629"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunologic Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Intercellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-2"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9008-11-1", "NameOfSubstance": "Interferons"}, {"RegistryNumber": "BBX060AN9V", "NameOfSubstance": "Hydrogen Peroxide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Rectal"}, {"QualifierName": [], "DescriptorName": "Administration, Topical"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Blood Transfusion, Autologous"}, {"QualifierName": ["drug therapy", "immunology", "metabolism"], "DescriptorName": "Diabetic Foot"}, {"QualifierName": [], "DescriptorName": "Hemorheology"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hydrogen Peroxide"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Immunologic Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intercellular Signaling Peptides and Proteins"}, {"QualifierName": ["immunology"], "DescriptorName": "Interferons"}, {"QualifierName": ["immunology"], "DescriptorName": "Interleukin-2"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["immunology"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "11", "Day": "16"}, {"Year": "2020", "Month": "3", "Day": "12"}, {"Year": "2020", "Month": "5", "Day": "7"}, {"Year": "2020", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32534720", "10.1016/j.amjms.2020.05.012", "S0002-9629(20)30185-3"]}}], "PubmedBookArticle": []}